Clinical Trials Logo
  1. Home
  2. Prevention
  3. NCT00535665

Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine

Prevention Clinical Trial

Official title:
The Clinical Trial of Pandemic Influenza Vaccine (Whole-Virion， Inactivated, Adjuvanted) on Healthy Adults by Randomized and Double-Blind Design: a Phase II Study

Clinical Trial Summary

A single center, randomized and double-blind phase II clinical trial is to be conducted in adults to evaluate the safety and immunogenicity of an inactivated pandemic influenza vaccine (whole-virion, aluminium-adjuvanted).

Clinical Trial Description

The vaccine to be investigated is producted in embryonated hen's eggs using an H5N1 reference strain NIBRG-14 which was prepared by NIBSC. The strain is a reassortant between A/Vietnam/1194/2004 and A/PR/8/34 by reverse genetics.

Total 400 volunteers aged from 18 to 60 years old are to be enrolled with 100 subjects in each group. The eligible volunteers will receive two doses vaccine of 5μg，10μg or 15μg haemagglutinin antigen. The schedule is day 0,14 or day 0,28. The subjects will donate their blood samples for the detection of HI antibody and microneutralization antibody. Local and systematic adverse reactions will be recorded during the study. ;

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00535665
Study type Interventional
Source Sinovac Biotech Co., Ltd
Contact
Status Completed
Phase Phase 2
Start date September 2007
Completion date November 2007
View Details
See also
  Status Clinical Trial Phase
Completed NCT05509049 - Precision Nudging Drives Wellness Visit Attendance at Scale N/A
Active, not recruiting NCT05667974 - A Study to Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried Phase 3
Not yet recruiting NCT06335121 - Implementation of PrEP Care Among Women in Family Planning Clinics N/A
Not yet recruiting NCT04082091 - Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
Terminated NCT01395238 - Enhancing Father's Ability to Support Their Preschool Child N/A
Completed NCT00589173 - An Interactive Preventive Health Record (IPHR) to Promote Patient-Centered Preventive Care N/A
Completed NCT00995462 - Prevention of Weight Gain in University Students N/A
Completed NCT00814554 - Effectiveness Evaluation of Three Strategies of Promotion of Healthy Dietary and Physical Activity Behaviours to Prevent Weight Excess Among Teenagers N/A
Completed NCT00966212 - Parent Education for Young Teen Females Phase 2/Phase 3
Completed NCT04526873 - Encouraging Annual Wellness Visits Among ACO Beneficiaries N/A
Recruiting NCT06112249 - SAFE Workplace Intervention for People With IDD N/A
Completed NCT04977700 - Using Physical Tracking to Predict Sunburn N/A
Completed NCT04032145 - Characterization of Health Conditions of Visitors of the Montreal Museum of Fine Arts
Completed NCT04785599 - Lymphedema Prevention After Lymph Node Emptying N/A
Recruiting NCT05050266 - Enhancing Mental and Physical Health of Women Veterans N/A
Recruiting NCT01021488 - Rosuvastatin for Preventing Deep Vein Thrombosis Phase 4
Terminated NCT02247258 - Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence. Phase 2
Recruiting NCT05903885 - A Cross-sectional Partnership to Improve Prevention N/A
Completed NCT04162977 - Adapting Personality-Targeted Interventions for Reducing Substance Misuse and Related Outcomes in Youth in Youth Protection Services N/A
Terminated NCT03192514 - Electronic Deprescribing Tool for the Prevention of PIP N/A